SmarTrend Watching for Potential Pullback in Shares of ABIOMED After 3.56% Gain
Comtex SmarTrend(R) - Fri Jul 29, 3:02PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $115.24 to a high of $119.93. Yesterday, the shares gained 3.6%, which took the trading range above the 3-day high of $116.45 on volume of 462,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABMD: 119.50 (+1.53)
Cepheid's (CPHD) Q2 Loss Narrower than Estimate, View Up
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:09PM CDT
Cepheid (CPHD) posted second-quarter 2016 adjusted loss per share of 9 cents.
BABY: 39.18 (-0.15), ABMD: 119.50 (+1.53), MASI: 52.93 (-0.04), CPHD: 36.76 (+1.43)
GNC Holdings (GNC) Tops Q2 Earnings, Suspends '16 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:01PM CDT
GNC Holdings (GNC) ended second-quarter 2016 on a disappointing note as its revenue figure failed to meet the Zacks Consensus Estimate.
BABY: 39.18 (-0.15), ABMD: 119.50 (+1.53), MASI: 52.93 (-0.04), GNC: 19.97 (-0.44)
Shares of ABMD Up 42.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jul 29, 12:54PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 5 months, ABIOMED has returned 42.24% as of today's recent price of $119.91.
ABMD: 119.50 (+1.53)
HCA Holdings (HCA) Beats Q2 Earnings, Raises FY16 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 10:12AM CDT
HCA Holdings Inc. (HCA) reported second-quarter 2016 adjusted earnings of $1.66 per share, which beat the Zacks Consensus Estimate by 11 cents.
HCA: 75.52 (-1.61), BABY: 39.18 (-0.15), ABMD: 119.50 (+1.53), WCG: 106.88 (+0.08)
ResMed (RMD) Q4 Earnings in Line, Revenues Top Estimates
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 9:14AM CDT
ResMed ended fiscal 2016 on a modest note, with fourth-quarter revenues beating estimates and earnings meeting the same.
BABY: 39.18 (-0.15), ABMD: 119.50 (+1.53), MASI: 52.93 (-0.04), RMD: 69.85 (+0.97)
Quality Systems (QSII) Lags Q1 Earnings, Issues FY17 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:35AM CDT
Quality Systems Inc. reported first-quarter 2017 adjusted earnings of 14 cents per share, below the Zacks Consensus Estimate of 18 cents.
ABMD: 119.50 (+1.53), ALGN: 89.69 (+0.54), AAC: 21.50 (-1.17), QSII: 12.20 (-0.08)
Thermo Fisher (TMO) Tops Q2 Earnings, Sales; Updates View
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 2:31PM CDT
Thermo Fisher's (TMO) financial numbers squarely beat the Zacks Consensus Estimate in the second quarter
BABY: 39.18 (-0.15), ABMD: 119.50 (+1.53), MASI: 52.93 (-0.04), TMO: 159.56 (+0.72)
Mead Johnson (MJN) Tops Q2 Earnings, Sales Down Y/Y (Revised)
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:43AM CDT
Mead Johnson's (MJN) second-quarter results were a mixed bag, with the bottom line comfortably beating the Zacks Consensus Estimate and revenues missing the same.
BABY: 39.18 (-0.15), ABMD: 119.50 (+1.53), MJN: 87.72 (-1.48), MASI: 52.93 (-0.04)
Varian Medical (VAR) Beats Q3 Earnings & Sales; View Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 10:15AM CDT
Varian Medical Systems Inc. (VAR) reported earnings of $1.22 per share in the third quarter of fiscal 2016, which beat the Zacks Consensus Estimate by a nickel.
BABY: 39.18 (-0.15), ABMD: 119.50 (+1.53), MASI: 52.93 (-0.04), VAR: 94.84 (+0.10)
Edwards Lifesciences (EW) Catches Eye: Stock Jumps 5.6%
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 7:40AM CDT
Edwards Lifesciences Corp. (EW) saw its shares rise almost 6% in the last trading session.
ABMD: 119.50 (+1.53), EW: 114.23 (-0.29)
Abiomed Announces Q1 FY 2017 Revenue of $103.0 Million, Up 40% Over Prior Year
GlobeNewswire - Thu Jul 28, 6:03AM CDT
Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2017 revenue of $103.0 million, an increase of 40% compared to revenue of $73.4 million for the same period of fiscal 2016. First quarter fiscal 2017 GAAP net income was $12.9 million or $0.29 per diluted share, compared to GAAP net income of $8.9 million or $0.20 per diluted share for the prior year period.
ABMD: 119.50 (+1.53)
Hologic (HOLX) Beats on Q3 Earnings, Sales; '16 View Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 5:29AM CDT
Hologic (HOLX) ended third-quarter fiscal 2016 on a promising note, with both its top and bottom line comfortably exceeding the Zacks Consensus Estimate.
BABY: 39.18 (-0.15), ABMD: 119.50 (+1.53), MASI: 52.93 (-0.04), HOLX: 38.98 (+0.49)
Illumina (ILMN) Beats Q2 Earnings, Revenues; EPS View Up
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 2:12PM CDT
Illumina (ILMN) ended the second quarter on an outstanding note, with both the top and bottom line results comfortably beating the Zacks Consensus Estimate.
ABMD: 119.50 (+1.53), MASI: 52.93 (-0.04), CYNO: 53.51 (-1.45), ILMN: 170.65 (+4.30)
Universal Health (UHS) Q2 Earnings In-Line, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 2:09PM CDT
Universal Health Services reported second-quarter 2016 adjusted earnings of $1.94 per share, in line with the Zacks Consensus Estimate.
ABMD: 119.50 (+1.53), UHS: 128.22 (-1.31), AHS: 43.31 (+1.01), MD: 68.99 (+0.08)
Short Interest In ABIOMED Jumps 21.6%
MarketNewsVideo.com - Wed Jul 27, 1:23PM CDT
The most recent short interest data has been released for the 07/15/2016 settlement date, which shows a 554,128 share increase in total short interest for ABIOMED, Inc. , to 3,115,836, an increase of 21.63% since 06/30/2016.
ABMD: 119.50 (+1.53)
Edwards Lifesciences (EW) Tops Q2 Earnings, '16 View Up
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 11:39AM CDT
Edwards Lifesciences (EW) ended the second quarter on an encouraging note, with its financial numbers squarely beating the Zacks Consensus Estimate.
ABMD: 119.50 (+1.53), MASI: 52.93 (-0.04), CYNO: 53.51 (-1.45), EW: 114.23 (-0.29)
Lumentum Holdings (LITE) in Focus: Stock Moves Up 10.9%
Zacks Equity Research - Zacks Investment Research - Tue Jul 26, 7:30AM CDT
Lumentum Holdings Limited (LITE) shares rose almost 11% in the last trading session.
ABMD: 119.50 (+1.53), LITE: 30.41 (+0.16)
AngioDynamics (ANGO) Tops Q4 Earnings, '17 View Positive
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 4:14PM CDT
Shares of AngioDynamics Inc. (ANGO) rallied almost 10%, after the company reported impressive fourth quarter fiscal 2016 results.
ABMD: 119.50 (+1.53), MASI: 52.93 (-0.04), MLAB: 114.10 (-1.53), ANGO: 16.52 (-0.07)